C-reactive protein: a surrogate risk marker or mediator of atherothrombosis?

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725 · see citing works

Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association

Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401 · see citing works

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · see citing works

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504 · see citing works

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus

Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433 · see citing works

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604 · see citing works

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513 · see citing works

C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women

Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292 · see citing works

Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells

Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,941 · see citing works

Effect of Statin Therapy on C-Reactive Protein Levels

Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,642 · see citing works

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557 · see citing works

Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., & D, E. B. M. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,479 · see citing works

Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels

Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., Moye, L. A., Goldman, S., Flaker, G. C., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.9.839 · Cited by 1,389 · see citing works

Novel Risk Factors for Systemic Atherosclerosis

Ridker, P. M., Stampfer, M. J., & Rifai, N. (2001) · JAMA · doi:10.1001/jama.285.19.2481 · Cited by 1,300 · see citing works

A Self-Fulfilling Prophecy

Verma, S., Wang, C., Li, S., Dumont, A. S., Fedak, P. W. M., Badiwala, M. V., Dhillon, B., Weisel, R. D., Li, R., Mickle, D. A. G., et al. (2002) · Circulation · doi:10.1161/01.cir.0000029802.88087.5e · Cited by 1,052 · see citing works

Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus

Haffner, S. M., Greenberg, A. S., Weston, W. M., Chen, H., Williams, K., & Freed, M. I. (2002) · Circulation · doi:10.1161/01.cir.0000025403.20953.23 · Cited by 882 · see citing works

Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells

Venugopal, S. K., Devaraj, S., Yuhanna, I. S., Shaul, P. W., & Jialal, I. (2002) · Circulation · doi:10.1161/01.cir.0000033116.22237.f9 · Cited by 849 · see citing works

C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages

Zwaka, T. P., Hombach, V., & Torzewski, J. (2001) · Circulation · doi:10.1161/01.cir.103.9.1194 · Cited by 845 · see citing works

C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy

Morrow, D. A., Rifai, N., Antman, E. M., Weiner, D. L., McCabe, C. H., Cannon, C. P., & D, E. B. M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00136-3 · Cited by 780 · see citing works

Novel Clinical Markers of Vascular Wall Inflammation

Blake, G. J., & Ridker, P. M. (2001) · Circulation Research · doi:10.1161/hh2101.099270 · Cited by 754 · see citing works

C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells

Devaraj, S., Xu, D. Y., & Jialal, I. (2003) · Circulation · doi:10.1161/01.cir.0000052617.91920.fd · Cited by 641 · see citing works

Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive Protein

Verma, S., Li, S., Badiwala, M. V., Weisel, R. D., Fedak, P. W. M., Li, R., Dhillon, B., & Mickle, D. A. G. (2002) · Circulation · doi:10.1161/01.cir.0000015126.83143.b4 · Cited by 634 · see citing works

Generation of C-Reactive Protein and Complement Components in Atherosclerotic Plaques

Yasojima, K., Schwab, C., McGeer, E. G., & McGeer, P. L. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64051-5 · Cited by 563 · see citing works

C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the Intima of Early Atherosclerotic Lesions of Human Coronary Arteries

Torzewski, J., Torzewski, M., Bowyer, D. E., Fröhlich, M., Köenig, W., Waltenberger, J. L., Fitzsimmons, C. M., & Hombach, V. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.9.1386 · Cited by 560 · see citing works

Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis

Heeschen, C., Hamm, C. W., Bruemmer, J., & Simoons, M. L. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00581-7 · Cited by 414 · see citing works

Variability and Classification Accuracy of Serial High-Sensitivity C-Reactive Protein Measurements in Healthy Adults

Ockene, I. S., Matthews, C. E., Rifai, N., Ridker, P. M., Reed, G. W., & Stanek, E. J. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.444 · Cited by 411 · see citing works

Thrombolysis in myocardial infarction

Cobbe, S. M. (1994) · BMJ · doi:10.1136/bmj.308.6923.216 · Cited by 297 · see citing works

A prospective evaluation of lipoprotein-associated phospholipase A2levels and the risk of future cardiovascular events in women

Blake, G. J., Dada, N., Fox, J. C., Manson, J. E., & Ridker, P. M. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01554-6 · Cited by 211 · see citing works

Modulation of C-Reactive Protein-Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis Drugs

Pasceri, V., Chang, J., Willerson, J. T., & Yeh, E. T. H. (2001) · Circulation · doi:10.1161/01.cir.103.21.2531 · Cited by 181 · see citing works

Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia

Blake, G. J., Ridker, P. M., & Kuntz, K. M. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00074-3 · Cited by 44 · see citing works

Projected life-expectancy gains with statin therapy for individuals with elevated c-reactive protein levels

Blake, G. J., Ridker, P. M., & Kuntz, K. M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01914-9 · Cited by 39 · see citing works

Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged men: a randomized-controlled trial

Thompson, D., Markovitch, D., Betts, J. A., Mazzatti, D., Turner, J., & Tyrrell, R. M. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00822.2009 · Cited by 123 · see citing works

A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis

Vodolazkaia, A., Bossuyt, X., Fassbender, A., Kyama, C. M., Meuleman, C., Peeraer, K., Tomassetti, C., & D'Hooghe, T. M. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-113 · Cited by 28 · see citing works

Thyroid disorders in patients with newly diagnosed rheumatoid arthritis is associated with poor initial treatment response evaluated by disease activity score in 28 joints-C-reactive protein (DAS28-CRP)

Emamifar, A., Hangaard, J., & Hansen, I. M. J. (2017) · Medicine · doi:10.1097/md.0000000000008357 · Cited by 33 · see citing works

C-Reactive Protein and Cardiovascular Disease: Cause, Mediator, or Marker?

Soloway, B. (2010) · Journal watch · doi:10.1056/jw201001280000003

Subclinical Hypothyroidism may be Associated with Elevated High-sensitive C-Reactive Protein (Low Grade Inflammation) and Fasting Hyperinsulinemia

Tuzcu, A., Bahçeci, M., Gökalp, D., Tüzün, Y., & GUNES, K. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.89 · Cited by 190 · see citing works

Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein

Hung, Y., Lin, S., Pei, D., Kuo, S., Hsieh, C., He, C., Lee, C., Fan, S. C., & Sheu, W. H. (2006) · Metabolism · doi:10.1016/j.metabol.2005.10.004 · Cited by 18 · see citing works

Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation

Matsubara, M., NAMIOKA, K., & Katayose, S. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480657 · Cited by 82 · see citing works